CHMP recommends EU approval of Roche's PiaSky for people with PNH, a rare, life-threatening blood condition

"People living with PNH face lifelong treatment, often requiring frequent intravenous infusions and timeconsuming clinic visits," said Levi Garraway, M.D., Ph.D., Roche's Chief Medical Officer and Head of Global Product Development. "With the option to self-administer once a month, today's recommendation may therefore offer patients and caregivers in Europe more freedom in their day-to-day lives." PiaSky is being investigated in a broad clinical development programme, including five ongoing Phase III studie ...